If you haven`t sold MRNA at all time high: Then analyzing the options chain and the chart patterns of MRNA Moderna prior to the earnings report this week, I would consider purchasing the 115usd strike price Calls with an expiration date of 2024-7-19, for a premium of approximately $8.00. If these options prove to be profitable prior to the earnings release, I...
Moderna ( NASDAQ:MRNA ) stock broke out for the first time in a year after beating Wall Street's first-quarter expectations as its second potential approval looms. The company hopes to win Food and Drug Administration approval for its RSV vaccine, which causes cold-like symptoms in most people but can be serious or deadly in babies and older adults. The FDA is due...
In a significant breakthrough for cancer treatment, Moderna's ( NASDAQ:MRNA ) individualized cancer vaccine, developed in collaboration with Merck, has shown remarkable promise in an early-stage trial targeting head and neck cancer. The encouraging results have ignited a surge in Moderna's stock price and injected fresh optimism into the field of oncology...
NASDAQ:MRNA Bearish to Bullish Reversal A "Bearish to Bullish Reversal" in technical analysis for NASDAQ:MRNA suggests a shift in the stock's price movement pattern from a downward trend (bearish) to an upward trend (bullish). This reversal typically occurs after a period of decline, indicating that the stock may be transitioning from a bearish phase to a...
Moderna ( NASDAQ:MRNA ), a biotechnology company at the forefront of mRNA technology, is experiencing a significant surge in its stock price, climbing over 10% to surpass the $114 per share mark. This rally marks Moderna's highest level since January, reflecting a remarkable turnaround from its challenges in 2023. The resurgence of Moderna's stock can be...
The biggest pharma giants are easy to recognize. Johnson and Johnson, Pfizer, Moderna, Merck & Co, Danaher Corp, Thermo Fisher Scientific. All medications and pharmaceutical drugs come out of these drug corporations. Lab equipment, medical research, vaccines, and other life science developments come out of these conglomerate pharma giants. Support and Resistance...
Moderna ( NASDAQ:MRNA ), the pioneering vaccine maker, reported a surprise fourth-quarter profit, sending ripples of optimism through the market. Bolstered by unexpected revenue and strategic cost-cutting measures, the company's resilience amid shifting tides in the pharmaceutical landscape has drawn both attention and applause. Unveiling the Numbers: Moderna's (...
This is a Technical Analysis on Moderna (MRNA) on the 1 Week Timeframe. Current price action shows that we are currently in the process of breaking a MAJOR SUPPORT Zone. We held critical SUPPORT multiple times ABOVE the $115.00 level, for a span of about 26 months. Expressed by the GREEN circles. But notice we havent been able to successfully rally and stay...
Informed Players and speculators at Sub $100 levels are booking gains we wait for additional drwadowns and re accomodation ACCUMULATION of designated Bankers for the next run up OR cycle Vaccine COViD was intense HiV was the sell on News.. we await next Drama and Biden Policy on Healthcare etc.. for now Watch or Chrun at key leves (eyeball the box)
There is a high probability that it can hit 250 in next 3 months, it must break above 170 first. Some big news around 170 can make it hit 250.
$MRNA started playing this since it was in the low $20s and then got rid of it at the start of this year. And IMO this is headed under $100. It will get a kick start when the next Pandemic happens and WHO rules lockdowns across the world. Regardless of the hype, I don't see any reason to take a position in this ticker. The only outcome is, EXIT for me :) Although...
$MRNA - Moderna breaking down. 50MA sloping down. Wave 3 of 5 Down Waves. See notations in chart. Just a technical thesis. Not investment advice...
Moderna's share (MRNA) price has been running in a narrow price range since November 8 after a series of gains extending since October 21, surpassing the short and long-term exponential moving averages in a positive short-term sign. Meanwhile, an unclear zigzag path has dominated MRNA share since the beginning of the year. As for now, and on the daily chart, we...
maybe this will rise as well when enough media covers the issue it seems a cycle since the outbreak
Moderna - 30d expiry - We look to Sell at 186.88 (stop at 198.38) Price action continued to range between key support & resistance (120 - 190) and we expect this to continue. Daily signals are mildly bearish. Posted a Double Top formation. An Evening Doji Star formation has been posted at the high. We look for a temporary move higher. Offers ample...
We have a lower high, compare this past 16-November to 4-August. We also have a clear bearish pattern in the form of a rising wedge. Going by the candlesticks, we can spot some bearish signals there as well. 16-Nov. Doji is a bearish candle. 18-Nov. another bearish candle, confirmation of the previous one. Today we gapped lower which gives strength to the...
Moderna has broken up above the 200MA... It looks good for upside along with the American rally with (lower than expected inflation rates, high GDP numbers and higher jobs). We just need a strong breakout above the Rectangle Box Formation before we have upside to $258.00.
Following daily. I got a long signal with my system. Hard TP 155.5 But I'll publish a dynamic SL and target. If you want to join trade, please follow my updates.